<DOC>
	<DOC>NCT01060969</DOC>
	<brief_summary>To evaluate the additive value of tadalafil given together with Diamox (acetazolamide) in preventing acute mountain sickness in travelers to high altitude areas.</brief_summary>
	<brief_title>Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention</brief_title>
	<detailed_description>A randomized controlled study comparing: Tadalafil [20mg x1/day] and acetazolamide [125mg x2 day], versus Acetazolamide [125mg x2 day] alone, in trekkers to altitude &gt; 3,000 m.</detailed_description>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Pulmonary Edema</mesh_term>
	<mesh_term>Altitude Sickness</mesh_term>
	<mesh_term>Brain Edema</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Participant in trekking to high altitude Agreement to sign the informed consent. No agreement to sign informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Acute Mountain Sickness</keyword>
	<keyword>travellers</keyword>
	<keyword>Acetazolamide</keyword>
	<keyword>Tadalafil</keyword>
	<keyword>Acute Mountain Sickness assessed by Lake Louise score</keyword>
	<keyword>High altitude pulmonary edema</keyword>
	<keyword>High altitude cerebral edema</keyword>
</DOC>